Shares of Cybin Inc. (OTCMKTS:CLXPF – Get Free Report) shot up 1.2% during trading on Thursday . The company traded as high as $8.3811 and last traded at $8.28. 717,701 shares traded hands during mid-day trading, an increase of 30% from the average session volume of 551,962 shares. The stock had previously closed at $8.18.
Cybin Stock Performance
The firm has a 50-day moving average price of $7.85 and a 200 day moving average price of $6.96. The company has a market cap of $1.23 billion and a price-to-earnings ratio of -59.14.
About Cybin
Cybin Inc (OTCMKTS: CLXPF) is a biotechnology company focused on the research, development and commercialization of psychedelic-based therapeutics for the treatment of mental health and wellness disorders. The company leverages proprietary drug discovery platforms to design novel analogues of psilocybin and other psychoactive compounds. Its programs aim to improve the safety, bioavailability and manufacturability of these molecules while addressing conditions such as depression, anxiety and substance use disorders.
Cybin’s pipeline encompasses several clinical and preclinical stage candidates.
Featured Articles
- Five stocks we like better than Cybin
- Think You Missed Silver? You’re Wrong. Here’s Why.
- Is Trump Done? Shocking leak…
- What a Former CIA Agent Knows About the Coming Collapse
- Trump’s AI Secret: 100X Faster Than Nvidia
- Is Elon Preparing for a Silver Shock?
Receive News & Ratings for Cybin Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cybin and related companies with MarketBeat.com's FREE daily email newsletter.
